The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Zhang, Kun ^a   Han, Xiaohui ^a   Zhang, Zhen ^a   Zheng, Lina ^a   Hu, Zhimei ^a   Yao, Qingbin ^a   Cui, Hongmei ^a   Shu, Guiming ^a   Si, Maojie ^a   Li, Chan ^a   Shi, Zhemin ^a   Chen, Ting ^a   Han, Yawei ^a   Chang, Yanan ^a   Yao, Zhi ^a   Han, Tao ^a,b   Hong, Wei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Third Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER FIBROSIS ASSOCIATED LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA; NOTCH RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; TRANSFORMING GROWTH FACTOR BETA1;

ACTIVATION ENERGY; APOPTOSIS; CELLS AND CELL COMPONENTS; CHEMICAL BINDING; CYTOPLASM; GENETIC ANALYSIS; RNA; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CELL ACTIVATION; CONTROLLED STUDY; CYTOPLASM; HEPATIC STELLATE CELL; IN VITRO STUDY; LIVER FIBROSIS; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL LINE; GENE EXPRESSION PROFILING; GENETICS; HEK293 CELL LINE; HUMAN; LIVER; LIVER CELL; LIVER CIRRHOSIS; MALE; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; APOPTOSIS; CELL LINE; CELLS, CULTURED; GENE EXPRESSION PROFILING; HEK293 CELLS; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, NOTCH; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85026328182     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-00204-4     Document Type: Article

References (29)

1. Bataller, R. & Brenner, D. A. Liver fibrosis. J. Clin. Invest. 115, 209-218 (2005).
2. Trautwein, C., Friedman, S. L., Schuppan, D. & Pinzani, M. Hepatic fibrosis: concept to treatment. J. Hepatol. 62, S15-24 (2015).
3. Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172 (2008).
4. Ulitsky, I. & Bartel, D. P. lincRNAs: genomics, evolution, and mechanisms. Cell 154, 26-46 (2013).
5. Li, P. et al. A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell. Metab. 21, 455-467 (2015).
6. Krol, J. et al. A network comprising short and long noncoding RNAs and RNA helicase controls mouse retina architecture. Nat. Commun. 6, 7305 (2015).
7. Zhang, K. et al. The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene 547, 1-9 (2014).
8. Prensner, J. R. & Chinnaiyan, A. M. The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391-407 (2011).
9. Yang, F. et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 54, 1679-1689 (2011).
10. Xu, D. et al. Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/beta-catenin signaling. Hepatology 58, 739-751 (2013).
11. Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493, 231-235 (2013).
12. Liu, Q. et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 41, 4976-4987 (2013).
13. Rapicavoli, N. A. et al. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife 2, e00762 (2013).
14. Zhou, C. et al. Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins. Genome Med. 8, 31 (2016).
15. Yu, F. et al. Long non-coding RNA growth arrest-specific transcript 5 (GAS5) inhibits liver fibrogenesis through a mechanism of competing endogenous RNA. J. Biol. Chem. 290, 28286-28298 (2015).
16. He, Y. et al. Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis. Biochim. Biophys. Acta 1842, 2204-2215 (2014).
17. Zhang, Y. et al. Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function. Sci. Rep. 6, 20559 (2016).
18. Seki, E. & Schwabe, R. F. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 61, 1066-1079 (2015).
19. Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147, 765-783. e764 (2014).
20. Suh, Y. G. et al. CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology 56, 1902-1912 (2012).
21. Clevers, H. & Nusse, R. Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205 (2012).
22. Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol. Rev. 94, 1287-1312 (2014).
23. Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233 (2009).
24. Xie, G. et al. Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice. Hepatology 58, 1801-1813 (2013).
25. Klattenhoff, C. A. et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 152, 570-583 (2013).
26. Sallam, T. et al. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis. Nature 534, 124-128 (2016).
27. Wang, K. et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat. Commun. 6, 6779 (2015).
28. Wang, K. et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat. Commun. 5, 3596 (2014).
29. Lee, Y. A., Wallace, M. C. & Friedman, S. L. Pathobiology of liver fibrosis: a translational success story. Gut 64, 830-841 (2015).